バイオバンクと全国レジストリを活用した全身性エリテマトーデス次世代治療薬の創製

• Project/Area Number: 25K02687
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 54020:Connective tissue disease and allergy-related
• Research Institution: Okayama University
• Principal Investigator: 松本 佳則 岡山大学, 大学病院, 研究准教授 (80803155)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000); Fiscal Year 2027: ¥5,980,000 (Direct Cost: ¥4,600,000、Indirect Cost: ¥1,380,000); Fiscal Year 2026: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000); Fiscal Year 2025: ¥7,670,000 (Direct Cost: ¥5,900,000、Indirect Cost: ¥1,770,000)